Consensus
The community is moderately leaning bullish on AstraZeneca at 62%, based on 6 forecasts. Forecasters are in moderate agreement.
Resolves YES if AstraZeneca's closing price on the resolve date is at or above $159.
Share your read on this question — the best forecasters show their work.
See the whole azn discussion →